YYD601 20mg

DRUG2 trials

Sponsors

Yooyoung Pharmaceutical Co., Ltd.

Conditions

GERDNon-erosive Reflux Disease

Phase 1

Clinical Trial to Assess the PK/PD of YYD601 20mg After Oral Administration if Healthy Adult Subjects (Phase1)

CompletedNCT03985319

Yooyoung Pharmaceutical Co., Ltd.GERD

Start: 2019-07-08End: 2020-03-20Updated: 2021-05-11

Phase 3

Clinical Trial to Assess the Efficacy and Safety of YYD601 in NERD Patients

CompletedNCT03967886

Yooyoung Pharmaceutical Co., Ltd.Non-erosive Reflux Disease

Start: 2019-04-10End: 2020-05-27Updated: 2021-05-11

Related Papers

A Pharmacokinetic/Pharmacodynamic Study of Esomeprazole Comparing a Dual Delayed-Release Formulation (YYD601) to a Conventional Formulation Following Multiple Administrations in Healthy Adult Subjects

Drug Design Development and Therapy2025-01-01